http://www.rheumatoid.org.uk/article.php?article_id=711"NRAS Medical Advisor, Prof. Peter Taylor, said “Not only is this
appalling news for patients and the Health Professionals who treat
them, but it is sending a clear message to the companies who are
currently investing in innovative medical research programmes into
inflammatory forms of arthritis that the UK market is becoming less
relevant and this is hugely detrimental to UK PLC"
Scary stuff!!
Copyright ArthritisInsight.com